Charles l. tomas (19 Ergebnisse)

Zustand: Good. 9th Edition. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

paperback. Zustand: Good. Our good condition books are generally good for reading but not for gifting or collecting. They could have imperfections such as creasing, fanning, inscriptions, margin notes, yellowing, staining on edge or cover or pages, bumps, scuffs, etc etc (sometimes multiple of these). It's a wide category that encompasses anything that isn't almost-new down to anything that is slightly better than poor. We would NOT recommend gifting Good books - these should be considered reading copies. Our books are dispatched from a Yorkshire former cotton mill. We list via barcode/ISBN so please note that the images are stock images and may not be the exact copy you receive, furthermore the details about edition and year might not be accurate as many publishers reuse the same ISBN for multiple editions and as we simply scan a barcode or enter an ISBN we do not check the validity of the edition data when listing. If you're looking for an exact edition please don't order (at least not without checking with us first, although we don't always have time to check). We aim to dispatch prompty, the service used will depend on order value and book size. We can ship to most countries, see our shipping policies. Payment is via Abe only.…

Zustand: Very Good. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

tapa blanda. Zustand: Bien. Historia.(93) Historia y Vida. Madrid. 1974. 22 cm. Encuadernación en tapa blanda de editorial. Cubierta deslucida. (=3409478=) HF26.

tapa blanda. Zustand: Bien. Historia.(93) Historia y Vida. Madrid. 1974. 22 cm. Encuadernación en tapa blanda de editorial. Cubierta deslucida. (=3408517=) HC54.

Zustand: BUONO USATO. Da revisionare Francese Brossura commerciale vintage, copertina segnata da aloni di pulviscolo, dissolvenza marcata al dorso, abrasioni con mende da conservazione e uso, pref. Dott. C. Veil, fogli ombrati da ossidazione bruna, intensa al margine e tagli, dove si annidano ombre di muffe. N. pag. 271.…

paperback. Zustand: Gut. 576 Seiten; 9780078112911.3 Gewicht in Gramm: 2.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Used. pp. 135.

Zustand: Used. pp. 135.

Paperback. Zustand: Brand New. 11 edition. 562 pages. 10.83x8.46x1.02 inches. In Stock.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.

Hardcover. Zustand: Brand New. 1st edition. 135 pages. 9.00x6.25x0.75 inches. In Stock.

Paperback. Zustand: Brand New. 12 edition. 10.63x8.50x0.87 inches. In Stock.

Zustand: Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher | Keine Beschreibung verfügbar.

Zustand: New. Editor(s): Sanchez, Tomas E.; Scott, Charles L. Num Pages: 135 pages. BIC Classification: MMG. Category: (G) General (US: Trade). Dimension: 238 x 167 x 15. Weight in Grams: 364. . 2013. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland.

Zustand: New. KlappentextrnrnCongress has exhibited a strong and ongoing interest in facilitating the development of new, innovative pharmaceuticals for the marketplace while reducing the cost of drugs to consumers. Policies pertaining to funding for research.

Buch. Zustand: Neu. Neuware - Congress has exhibited a strong and ongoing interest in facilitating the development of new, innovative pharmaceuticals for the marketplace while reducing the cost of drugs to consumers. Policies pertaining to funding for research and development (R&D), intellectual property protection, and co-operative ventures have played an important role in the economic success of the pharmaceutical sector. Industry-specific legislation, also work to encourage innovation in the pharmaceutical sector while facilitating the entry of lower cost generic competition. While many factors contribute to innovation in the brand pharmaceutical industry and its ability to bring new and inventive products to the marketplace, this sector is facing significant issues associated with loss of revenue for additional R&D due to patent expirations and generic competition. This book examines the challenges associated with striking the proper balance between lower cost drugs and maintaining an innovative domestic pharmaceutical sector.…